Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Vorolanib Combined With Cadonilimab in the Treatment of Untreated Advanced RCC PatientsFemale Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, benign urinary system neoplasm, carcinoma, epithelial neoplasm, kidney cancer, kidney disorder, neoplasm, renal cell carcinoma, urinary system disorderNot yet recruitingPhase 1 / Phase 22024-08-29NCT06577961

1 results · Page 1 of 1

Swipe the table sideways for more columns.

0 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
No products are listed yet.